Connor, Clark & Lunn Investment Management (CC&L)’s BioAtla BCAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-117,552
| Closed | -$161K | – | 1441 |
|
|
2024
Q2 | $161K | Sell |
117,552
-116,385
| -50% | -$159K | ﹤0.01% | 1282 |
|
|
2024
Q1 | $805K | Buy |
233,937
+99,771
| +74% | +$343K | ﹤0.01% | 948 |
|
|
2023
Q4 | $330K | Sell |
134,166
-10,386
| -7% | -$25.6K | ﹤0.01% | 1150 |
|
|
2023
Q3 | $246K | Sell |
144,552
-4,112
| -3% | -$6.99K | ﹤0.01% | 1194 |
|
|
2023
Q2 | $446K | Buy |
148,664
+100,050
| +206% | +$300K | ﹤0.01% | 1018 |
|
|
2023
Q1 | $130K | Buy |
+48,614
| New | +$130K | ﹤0.01% | 1134 |
|